cefadroxil
Generic: cefadroxil
Labeler: aurobindo pharma limitedDrug Facts
Product Profile
Brand Name
cefadroxil
Generic Name
cefadroxil
Labeler
aurobindo pharma limited
Dosage Form
POWDER, FOR SUSPENSION
Routes
Active Ingredients
cefadroxil 500 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
65862-084
Product ID
65862-084_74923cbc-7511-447d-b6b2-b2d0e805a0f5
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA065349
Listing Expiration
2026-12-31
Marketing Start
2013-04-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
65862084
Hyphenated Format
65862-084
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
cefadroxil (source: ndc)
Generic Name
cefadroxil (source: ndc)
Application Number
ANDA065349 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 500 mg/5mL
Packaging
- 100 mL in 1 BOTTLE (65862-084-01)
- 50 mL in 1 BOTTLE (65862-084-50)
- 75 mL in 1 BOTTLE (65862-084-75)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "74923cbc-7511-447d-b6b2-b2d0e805a0f5", "openfda": {"unii": ["280111G160"], "rxcui": ["105171", "309048"], "spl_set_id": ["776a8dbc-e68e-4732-acf4-0133dca0f54c"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (65862-084-01)", "package_ndc": "65862-084-01", "marketing_start_date": "20130425"}, {"sample": false, "description": "50 mL in 1 BOTTLE (65862-084-50)", "package_ndc": "65862-084-50", "marketing_start_date": "20130425"}, {"sample": false, "description": "75 mL in 1 BOTTLE (65862-084-75)", "package_ndc": "65862-084-75", "marketing_start_date": "20130425"}], "brand_name": "Cefadroxil", "product_id": "65862-084_74923cbc-7511-447d-b6b2-b2d0e805a0f5", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Cephalosporin Antibacterial [EPC]", "Cephalosporins [CS]"], "product_ndc": "65862-084", "generic_name": "Cefadroxil", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cefadroxil", "active_ingredients": [{"name": "CEFADROXIL", "strength": "500 mg/5mL"}], "application_number": "ANDA065349", "marketing_category": "ANDA", "marketing_start_date": "20130425", "listing_expiration_date": "20261231"}